← SynDRA
SGI-1027
SynDRA canonical compound SYN0087298 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | DNMT3B |
|---|
| Mechanism of action | DNA methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- DNMT inhibitor
- DNMT1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- RefChem:182671
- DNA Methyltransferase Inhibitor II
- MFCD27937047
- SGI1027
- C27H23N7O
- GTPL8891
- orb1307169
- SCHEMBL3655385
- SCHEMBL29351315
- GLXC-05369
- HMS3653O06
- HMS3748A21
- EX-A2160
- VQB14973
- BDBM50430056
- EBC-11029
- FD5030
- NSC783333
- s7276
- SGI-1027?
- AKOS024458519
- CCG-269354
- NSC-783333
- SB19043
- NCGC00381561-65
- AC-33115
- AS-74078
- DA-48337
- HY-13962
- SGI-1027, >=98% (HPLC)
- SW220204-1
- T1904
- EN300-189631
- F865516
- BRD-K61228301-001-01-2
- Z1880962221
- SGI 1027
Look up SGI-1027 in the interactive SynDRA portal →